The JN.1 Novavax vaccine is an alternative to the LP.8.1 Pfizer-BioNTech and Moderna vaccines that were rolled out in October ...
Those eligible for the Novavax Covid-19 vaccine can receive the jab at selected general practitioner (GP) clinics from Jan 2 ...
Let’s dive into details regarding each of the evaluated factors, but first, for quick context: With $143 Bil in market ...
BioNTech SE (NASDAQ:BNTX) is one of the Stocks That Will Go To The Moon in 2026. On December 18, BioNTech SE (NASDAQ:BNTX) ...
BioNTech SE ( ($BNTX) ) has provided an update. On December 18, 2025, BioNTech SE announced it had closed its acquisition of CureVac N.V., ...
The Chosun Ilbo on MSNOpinion
mRNA vaccine phase 1 again, begging US pharma?
I was taken aback to hear the government had selected GC Biopharma as a company to support in phase 1 (first-stage clinical ...
Pfizer previews 2026 guidance with earnings below consensus, softer sales outlook, COVID decline and LOE headwinds offset by pipeline growth.
BioNTech has completed its exchange offer to acquire CureVacAcquisition complements BioNTech’s capabilities and proprietary technologies in mRNA design, delivery formulations, and mRNA manufacturingIn ...
Temporary side-effects may occur after any COVID vaccination, says the Public Health Agency of Canada spokesperson. These can vary, depending on a person's age and health status, Maddison said, but ...
These deals radically reshaped the biopharma world, either by one vaccine rival absorbing another, a Big Pharma doubling down ...
An estimated 100,000 vacancies in the NHS are currently unfilled, according to a November analysis by the healthcare charity, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback